"Meet Pingshan · Foresee the future" - Guangdong-Hong Kong-Macao Greater Bay Area Industry Association leaders into Shenzhen Cell Valley
“遇见坪山·预见未来”—粤港澳大湾区行业协会领导一行走进深圳细胞谷
On November 24, 2023, the 7th industrial chain innovation salon of "Meet Pingshan · Foresee the Future", sponsored by the Organization Department of Pingshan District Party Committee and hosted by Pingshan District High-level Talent Association, was held as scheduled. Yu Changhai, Chairman of Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Alliance, Chairman of Hong Kong Biotechnology Association, Professor of Peking University; Zhang Wenzhong, head of Shenzhen Branch of Guangdong Medical Device Quality Supervision and Inspection Institute; Mai Qiuhong, Member and Deputy Secretary of Pingshan Biomedical Industry Party Committee; Accompanied by Wang Huifang, Secretary General of Pingshan District High-level Talents Association, Mr. Qiu Jiazhou, chairman of Hegede Biotechnology (Shenzhen) Co., Ltd. and other leaders and enterprise representatives, came to Shenzhen Cell Valley to discuss the development and future of cell and gene therapy industry.
Sun Rui, Director of the Market Development Department, introduced the products and services of Shenzhen Cell Valley to the visiting guests, as well as the breakthrough achievements in the transformation and application of pharmaceutical innovation.
At the symposium, Chairman Shi Yuanyuan thanked the guests for coming, and introduced that Shenzhen Cell Valley has mastered the only domestic industrial production technology of retrovirus vector, and is committed to solving the "stuck neck" technology of industrial production of core raw materials in cell therapy drugs. Rapidly promote the transformation and commercial production of scientific research results, and empower the cutting-edge technology drive in the field of biomedicine by giving play to the strength of core technologies and talent absorption and industrial aggregation. Chairman Yu Changhai spoke highly of the service spirit of Shenzhen Cell Valley, as a one-stop service platform for cell and gene therapy, driven by continuous innovative cutting-edge technologies and targeted training of professionals, and committed to the high-quality development of the cell therapy industry. Chairman Yu Changhai said that cell and gene therapy is one of the most forward-looking industry tracks representing the new development of innovative technology, biomedicine is a key development area of Shenzhen-Hong Kong scientific and technological innovation, and the establishment of a public service platform is of great significance to Shenzhen-Hong Kong biomedicine collaborative innovation, helping to promote Shenzhen-Hong Kong biomedicine to play a leading and exemplary role in the Greater Bay Area and the world.
Subsequently, under the leadership of Chairman Shi Yuanyuan, the visiting leaders and enterprise representatives visited the smart exhibition hall and GMP production workshop and R & D laboratory, and had a deeper understanding of the company's development history, core team, core technology platform and production pipeline.
Meet Pyeongsan this time. The "Industry Chain Innovation Salon" event was successfully held, which promoted the exchanges between the biomedical industry of Shenzhen and Hong Kong, enhanced the upstream and downstream industrial chain interconnection, and laid the foundation for the exchange and cooperation between Shenzhen Cell Valley and Hong Kong cell gene therapy research institutions and enterprises.
